Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ian Zagon
Pennsylvania State Univ Hershey Med Ctr, Department: Neurosciences
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ocunova
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Ian Zagon, Dr. Patricia McLaughlin, and Dr. Joseph Sassani hold equity interest in a start-up company, Ocunova. The start-up company stems from an option agreement between PSU and Ocunova for intellectual property rights related to dry eye, a novel patented naltrexone treatment formulation.
OGF-OGFr Axis Modulation to Prevent Diabetic Ocular Surface Complications.
Project Narrative Nearly 1.5 million adults in the United States have type 1diabetes (T1D), and many will develop ocular surface complications such as corneal abrasions, dry eye, and ocular surface insensitivity. There is a compelling unmet medical need to understand the etiology and pathophysiology of T1D complications and to establish disease- based therapy for prevention of cell proliferative defects related to T1D. The proposed research focuses on dysregulation of the OGF-OGFr regulatory pathway as a cause of these ocular surface complications, and will investigate the role of naltrexone blockade of this pathway in the etiology and pathogenesis of diabetic corneal complications.
Filed on October 03, 2018.
Tell us what you know about Ian Zagon's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.